Iovance Biotherapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Iovance Biotherapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- IOVA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001425205
Board of directors
-
Athena Countouriotis · DirectorSince 2023
-
Frederick G. Vogt · Director · Interim CEO & General CounselSince 2024
-
Iain D. Dukes · DirectorSince 2023
-
Merrill A. Mcpeak · DirectorSince 2023
-
Michael Weiser · DirectorSince 2023
-
Ryan D. Maynard · DirectorSince 2023
-
Wayne P. Rothbaum · DirectorSince 2023
-
Wendy L. Yarno · DirectorSince 2023
Chief executives
Dates unknown
Board connections
4 of this board's directors also sit on 8 other boards.
- via Athena Countouriotis
- via Wendy L. Yarno
- via Iain D. Dukes
- via Wendy L. Yarno
- via Athena Countouriotis
- via Merrill A. Mcpeak
- via Wendy L. Yarno
- via Iain D. Dukes
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 14, 2025 | Puri Raj K. Officer (Chief Regulatory Officer) | Option exercise | +8,334 | — | — |
| Mar 14, 2025 | Puri Raj K. Officer (Chief Regulatory Officer) | Shares withheld for tax | −2,509 | $3.59 | $9,007 |
| Mar 3, 2025 | Bellemin Jean-Marc Officer (Chief Financial Officer) | Option exercise | +58,590 | — | — |
| Mar 3, 2025 | BILINSKY IGOR Officer (Chief Operating Officer) | Option exercise | +62,106 | — | — |
| Mar 3, 2025 | Frederick G. Vogt Director, Officer (Interim CEO & General Counsel) | Option exercise | +223,943 | — | — |
| Mar 3, 2025 | Puri Raj K. Officer (Chief Regulatory Officer) | Option exercise | +59,999 | — | — |
| Mar 3, 2025 | GRAF FINCKENSTEIN FRIEDRICH Officer (Chief Medical Officer) | Option exercise | +62,497 | — | — |
| Mar 3, 2025 | Bellemin Jean-Marc Officer (Chief Financial Officer) | Shares withheld for tax | −31,734 | $4.04 | $128,205 |
| Mar 3, 2025 | BILINSKY IGOR Officer (Chief Operating Officer) | Shares withheld for tax | −33,302 | $4.04 | $134,540 |
| Mar 3, 2025 | Frederick G. Vogt Director, Officer (Interim CEO & General Counsel) | Shares withheld for tax | −95,413 | $4.04 | $385,469 |
| Mar 3, 2025 | Puri Raj K. Officer (Chief Regulatory Officer) | Shares withheld for tax | −19,984 | $4.04 | $80,735 |
| Mar 3, 2025 | GRAF FINCKENSTEIN FRIEDRICH Officer (Chief Medical Officer) | Shares withheld for tax | −33,470 | $4.04 | $135,219 |
| Jan 14, 2025 | Frederick G. Vogt Director, Officer (Interim CEO & General Counsel) | Option exercise | +20,835 | — | — |
| Jan 14, 2025 | GRAF FINCKENSTEIN FRIEDRICH Officer (Chief Medical Officer) | Option exercise | +2,813 | — | — |
| Jan 14, 2025 | BILINSKY IGOR Officer (Chief Operating Officer) | Option exercise | +2,813 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.